Lab-Grown immune cells deployed to fight virus in vulnerable patients
NCT ID NCT03425526
Summary
This early-stage study is testing a new treatment for adenovirus infections in people with weakened immune systems, such as cancer patients. Doctors are giving patients specially grown immune cells (T-cells) from healthy donors that are trained to attack the adenovirus. The main goals are to see if this treatment is safe and to get early signs of whether it can help clear the virus.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNOCOMPROMISED are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
M D Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.